Concepedia

Andrew F. Wilks

AF

Statistics

Publications

71

Citations

10.7K

H-Index

44

Active since

1980

Affiliations

Ludwig Cancer Research(Current)

The Royal Melbourne Hospital

The University of Melbourne

University of Bern

Walter and Eliza Hall Institute of Medical Research

Andrew F. Wilks is an author at Ludwig Cancer Research specializing in life sciences, molecular biology, and signal transduction.

ORCID

Publications per year

1980–2017

71

Publications

71

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

Marc G. Achen, Michael Jeltsch, Eola Kukk et al. · Proceedings of the National Academy of Sciences · 1998 · 1.2K citations

, , +15

Association of Transcription Factor APRF and Protein Kinase Jak1 with the Interleukin-6 Signal Transducer gp130

Claudia Lütticken, Ursula Maria Wegenka, Juping Yuan et al. · Science · 1994 · 823 citations

, , +15

The protein tyrosine kinase JAK1 complements defects in interferon-α/β and -γ signal transduction

Mathias Müller, James Briscoe, Carl Laxton et al. · Nature · 1993 · 771 citations

, , +12

Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death

Joanne M. Hildebrand, Maria C. Tanzer, Isabelle S. Lucet et al. · Proceedings of the National Academy of Sciences · 2014 · 596 citations · Full text

, , +15

Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins

Ke Shuai, Andrew Ziemiecki, Andrew F. Wilks et al. · Nature · 1993 · 514 citations

, , +13

1–5 of 71